1.Does pulmonary metastasectomy of colorectal metastases translate to better survival? A systematic review.
Kai Yin LEE ; Jerrald LAU ; Bei En SIEW ; Yong Kang CHUA ; Yi Xuan LIM ; Xin Yi LIM ; Choon Seng CHONG ; Ker Kan TAN
Annals of the Academy of Medicine, Singapore 2021;50(10):773-781
INTRODUCTION:
Surgical resection of the primary and metastatic tumour is increasingly recommended in suitable patients with metastatic colorectal cancer (CRC). While the role of metastasectomy is well studied and established in colorectal liver metastasis, evidence remains limited in pulmonary metastases. This systematic review was conducted to examine the current evidence on the role of lung metastasectomy (LUM) in CRC.
METHODS:
Three databases were systematically searched, to identify studies that compared survival outcomes of LUM, and factors that affected decision for LUM.
RESULTS:
From a total of 5,477 records, 6 studies were eventually identified. Two papers reported findings from one randomised controlled trial and 4 were retrospective reviews. There was no clear survival benefit in patients who underwent LUM compared to those who did not. When compared against patients who underwent liver metastasectomy, there was also no clear survival benefit. Patients who underwent LUM were also more likely to have a single pulmonary tumour, and metachronous disease.
CONCLUSION
The evidence suggests a role for LUM, but is limited by inherent selection bias in retrospective reviews, and the single randomised clinical trial performed was not completed. More prospective studies are required to understand the true effect of LUM on outcomes in metastatic CRC.
Colorectal Neoplasms/surgery*
;
Humans
;
Liver Neoplasms/surgery*
;
Lung Neoplasms/surgery*
;
Metastasectomy
;
Pneumonectomy
;
Prognosis
;
Randomized Controlled Trials as Topic
;
Retrospective Studies
;
Survival Rate
2.Determinants of Willingness to Undergo Lung Cancer Screening among High- Risk Current and Ex-smokers in Sabah, Malaysia: A Cross-Sectional Pilot Study
Larry Ellee NYANTI ; Chia Zhen CHUA ; Han Chuan LOO ; Cheng Zhi KHOR ; Emilia Sheau Yuin TOH ; Rasvinder Singh GILL ; Eng Tat CHAN ; Ker Yin TAN ; Taufiq ROSLI ; Muhammad Aklil Abd RAHIM ; Arfian IBRAHIM ; Nai Chien HUAN ; Hema Yamini Devi RAMARMUTY ; Kunji Kannan Sivaraman KANNAN
Tuberculosis and Respiratory Diseases 2023;86(4):284-293
Background:
Attitudes towards smoking, lung cancer screening, and perceived risk of lung cancer have not been widely studied in Malaysia. The primary objective of this study was to describe the factors affecting the willingness of high-risk current smokers and ex-smokers to undergo low-dose computed tomography (LDCT) screening for lung cancer.
Methods:
A prospective, cross-sectional questionnaire study was conducted in current smokers or ex-smokers aged between 55 and 80 years at three hospitals in Kota Kinabalu, Sabah, Malaysia. The questionnaire recorded the following parameters: perceived lung cancer risk; Prostate Lung Colon Ovarian Cancer 2012 risk prediction model excluding race and ethnicity predictor (PLCOm2012norace); demographic characteristics; psychosocial characteristics; and attitudes towards lung cancer and lung cancer screening.
Results:
A vast majority of the 95 respondents (94.7%) indicated their willingness to undergo screening. Stigma of lung cancer, low levels of knowledge about lung cancer symptoms, concerns about financial constraints, and a preference for traditional medication were still prevalent among the respondents, and they may represent potential barriers to lung cancer screening uptake. A desire to have an early diagnosis (odds ratio [OR], 11.33; 95% confidence interval [CI], 1.53 to 84.05; p=0.02), perceived time constraints (OR, 3.94; 95% CI, 1.32 to 11.73; p=0.01), and proximity of LDCT screening facilities (OR, 14.33; 95% CI, 1.84 to 111.4; p=0.01) had significantly higher odds of willingness to undergo screening.
Conclusion
Although high-risk current smokers and ex-smokers are likely to undergo screening for lung cancer, several psychosocial barriers persist. The results of this study may guide the policymakers and clinicians regarding the need to improve lung cancer awareness in our population.